The University of Utah has been awarded a $824,512 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "DIGITAL PATHOLOGY PREDICTIONS OF TREATMENT RESPONSE IN HORMONE-SENSITIVE PROSTATE CANCER". The award, effective June 1, 2024, will support the university's research activities over a 3-year period through May 31, 2027. The goal of this project is to leverage digital pathology techniques to improve the prediction of treatment response in patients with hormone-sensitive prostate cancer, with the aim of advancing medical solutions for military personnel and the broader public.
Generated 2/25/25, 4:35 AM